- IBDEI10O ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,16535,2)
- ;;=^5001108
- ;;^UTILITY(U,$J,358.3,16536,0)
- ;;=C22.0^^61^775^104
- ;;^UTILITY(U,$J,358.3,16536,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16536,1,3,0)
- ;;=3^Liver Cell Carcinoma
- ;;^UTILITY(U,$J,358.3,16536,1,4,0)
- ;;=4^C22.0
- ;;^UTILITY(U,$J,358.3,16536,2)
- ;;=^5000933
- ;;^UTILITY(U,$J,358.3,16537,0)
- ;;=D05.02^^61^775^105
- ;;^UTILITY(U,$J,358.3,16537,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16537,1,3,0)
- ;;=3^Lobular Carcinoma in Situ,Left Breast
- ;;^UTILITY(U,$J,358.3,16537,1,4,0)
- ;;=4^D05.02
- ;;^UTILITY(U,$J,358.3,16537,2)
- ;;=^5001928
- ;;^UTILITY(U,$J,358.3,16538,0)
- ;;=D05.01^^61^775^106
- ;;^UTILITY(U,$J,358.3,16538,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16538,1,3,0)
- ;;=3^Lobular Carcinoma in Situ,Right Breast
- ;;^UTILITY(U,$J,358.3,16538,1,4,0)
- ;;=4^D05.01
- ;;^UTILITY(U,$J,358.3,16538,2)
- ;;=^5001927
- ;;^UTILITY(U,$J,358.3,16539,0)
- ;;=D05.00^^61^775^107
- ;;^UTILITY(U,$J,358.3,16539,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16539,1,3,0)
- ;;=3^Lobular Carcinoma in Situ,Unspec Breast
- ;;^UTILITY(U,$J,358.3,16539,1,4,0)
- ;;=4^D05.00
- ;;^UTILITY(U,$J,358.3,16539,2)
- ;;=^5001926
- ;;^UTILITY(U,$J,358.3,16540,0)
- ;;=R59.0^^61^775^66
- ;;^UTILITY(U,$J,358.3,16540,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16540,1,3,0)
- ;;=3^Enlarged Lymph Nodes,Localized
- ;;^UTILITY(U,$J,358.3,16540,1,4,0)
- ;;=4^R59.0
- ;;^UTILITY(U,$J,358.3,16540,2)
- ;;=^5019529
- ;;^UTILITY(U,$J,358.3,16541,0)
- ;;=C83.59^^61^775^108
- ;;^UTILITY(U,$J,358.3,16541,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16541,1,3,0)
- ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
- ;;^UTILITY(U,$J,358.3,16541,1,4,0)
- ;;=4^C83.59
- ;;^UTILITY(U,$J,358.3,16541,2)
- ;;=^5001590
- ;;^UTILITY(U,$J,358.3,16542,0)
- ;;=C83.50^^61^775^109
- ;;^UTILITY(U,$J,358.3,16542,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16542,1,3,0)
- ;;=3^Lymphoblastic Lymphoma,Unspec Site
- ;;^UTILITY(U,$J,358.3,16542,1,4,0)
- ;;=4^C83.50
- ;;^UTILITY(U,$J,358.3,16542,2)
- ;;=^5001581
- ;;^UTILITY(U,$J,358.3,16543,0)
- ;;=C43.9^^61^775^112
- ;;^UTILITY(U,$J,358.3,16543,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16543,1,3,0)
- ;;=3^Malig Melanoma of Skin,Unspec Site
- ;;^UTILITY(U,$J,358.3,16543,1,4,0)
- ;;=4^C43.9
- ;;^UTILITY(U,$J,358.3,16543,2)
- ;;=^5001015
- ;;^UTILITY(U,$J,358.3,16544,0)
- ;;=C31.9^^61^775^113
- ;;^UTILITY(U,$J,358.3,16544,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16544,1,3,0)
- ;;=3^Malig Neop Accessory Sinus,Unspec
- ;;^UTILITY(U,$J,358.3,16544,1,4,0)
- ;;=4^C31.9
- ;;^UTILITY(U,$J,358.3,16544,2)
- ;;=^5000953
- ;;^UTILITY(U,$J,358.3,16545,0)
- ;;=C24.1^^61^775^115
- ;;^UTILITY(U,$J,358.3,16545,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16545,1,3,0)
- ;;=3^Malig Neop Ampulla of Vater
- ;;^UTILITY(U,$J,358.3,16545,1,4,0)
- ;;=4^C24.1
- ;;^UTILITY(U,$J,358.3,16545,2)
- ;;=^267100
- ;;^UTILITY(U,$J,358.3,16546,0)
- ;;=C21.0^^61^775^116
- ;;^UTILITY(U,$J,358.3,16546,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16546,1,3,0)
- ;;=3^Malig Neop Anus,Unspec
- ;;^UTILITY(U,$J,358.3,16546,1,4,0)
- ;;=4^C21.0
- ;;^UTILITY(U,$J,358.3,16546,2)
- ;;=^5000930
- ;;^UTILITY(U,$J,358.3,16547,0)
- ;;=C67.9^^61^775^119
- ;;^UTILITY(U,$J,358.3,16547,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,16547,1,3,0)
- ;;=3^Malig Neop Bladder,Unspec
- ;;^UTILITY(U,$J,358.3,16547,1,4,0)
- ;;=4^C67.9
- ;;^UTILITY(U,$J,358.3,16547,2)
- ;;=^5001263
- ;;^UTILITY(U,$J,358.3,16548,0)
- ;;=C71.9^^61^775^123
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10O 3781 printed Feb 18, 2025@23:25:49 Page 2
- IBDEI10O ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,16535,2)
- +2 ;;=^5001108
- +3 ;;^UTILITY(U,$J,358.3,16536,0)
- +4 ;;=C22.0^^61^775^104
- +5 ;;^UTILITY(U,$J,358.3,16536,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,16536,1,3,0)
- +8 ;;=3^Liver Cell Carcinoma
- +9 ;;^UTILITY(U,$J,358.3,16536,1,4,0)
- +10 ;;=4^C22.0
- +11 ;;^UTILITY(U,$J,358.3,16536,2)
- +12 ;;=^5000933
- +13 ;;^UTILITY(U,$J,358.3,16537,0)
- +14 ;;=D05.02^^61^775^105
- +15 ;;^UTILITY(U,$J,358.3,16537,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,16537,1,3,0)
- +18 ;;=3^Lobular Carcinoma in Situ,Left Breast
- +19 ;;^UTILITY(U,$J,358.3,16537,1,4,0)
- +20 ;;=4^D05.02
- +21 ;;^UTILITY(U,$J,358.3,16537,2)
- +22 ;;=^5001928
- +23 ;;^UTILITY(U,$J,358.3,16538,0)
- +24 ;;=D05.01^^61^775^106
- +25 ;;^UTILITY(U,$J,358.3,16538,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,16538,1,3,0)
- +28 ;;=3^Lobular Carcinoma in Situ,Right Breast
- +29 ;;^UTILITY(U,$J,358.3,16538,1,4,0)
- +30 ;;=4^D05.01
- +31 ;;^UTILITY(U,$J,358.3,16538,2)
- +32 ;;=^5001927
- +33 ;;^UTILITY(U,$J,358.3,16539,0)
- +34 ;;=D05.00^^61^775^107
- +35 ;;^UTILITY(U,$J,358.3,16539,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,16539,1,3,0)
- +38 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
- +39 ;;^UTILITY(U,$J,358.3,16539,1,4,0)
- +40 ;;=4^D05.00
- +41 ;;^UTILITY(U,$J,358.3,16539,2)
- +42 ;;=^5001926
- +43 ;;^UTILITY(U,$J,358.3,16540,0)
- +44 ;;=R59.0^^61^775^66
- +45 ;;^UTILITY(U,$J,358.3,16540,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,16540,1,3,0)
- +48 ;;=3^Enlarged Lymph Nodes,Localized
- +49 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
- +50 ;;=4^R59.0
- +51 ;;^UTILITY(U,$J,358.3,16540,2)
- +52 ;;=^5019529
- +53 ;;^UTILITY(U,$J,358.3,16541,0)
- +54 ;;=C83.59^^61^775^108
- +55 ;;^UTILITY(U,$J,358.3,16541,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,16541,1,3,0)
- +58 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
- +59 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
- +60 ;;=4^C83.59
- +61 ;;^UTILITY(U,$J,358.3,16541,2)
- +62 ;;=^5001590
- +63 ;;^UTILITY(U,$J,358.3,16542,0)
- +64 ;;=C83.50^^61^775^109
- +65 ;;^UTILITY(U,$J,358.3,16542,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,16542,1,3,0)
- +68 ;;=3^Lymphoblastic Lymphoma,Unspec Site
- +69 ;;^UTILITY(U,$J,358.3,16542,1,4,0)
- +70 ;;=4^C83.50
- +71 ;;^UTILITY(U,$J,358.3,16542,2)
- +72 ;;=^5001581
- +73 ;;^UTILITY(U,$J,358.3,16543,0)
- +74 ;;=C43.9^^61^775^112
- +75 ;;^UTILITY(U,$J,358.3,16543,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,16543,1,3,0)
- +78 ;;=3^Malig Melanoma of Skin,Unspec Site
- +79 ;;^UTILITY(U,$J,358.3,16543,1,4,0)
- +80 ;;=4^C43.9
- +81 ;;^UTILITY(U,$J,358.3,16543,2)
- +82 ;;=^5001015
- +83 ;;^UTILITY(U,$J,358.3,16544,0)
- +84 ;;=C31.9^^61^775^113
- +85 ;;^UTILITY(U,$J,358.3,16544,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,16544,1,3,0)
- +88 ;;=3^Malig Neop Accessory Sinus,Unspec
- +89 ;;^UTILITY(U,$J,358.3,16544,1,4,0)
- +90 ;;=4^C31.9
- +91 ;;^UTILITY(U,$J,358.3,16544,2)
- +92 ;;=^5000953
- +93 ;;^UTILITY(U,$J,358.3,16545,0)
- +94 ;;=C24.1^^61^775^115
- +95 ;;^UTILITY(U,$J,358.3,16545,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,16545,1,3,0)
- +98 ;;=3^Malig Neop Ampulla of Vater
- +99 ;;^UTILITY(U,$J,358.3,16545,1,4,0)
- +100 ;;=4^C24.1
- +101 ;;^UTILITY(U,$J,358.3,16545,2)
- +102 ;;=^267100
- +103 ;;^UTILITY(U,$J,358.3,16546,0)
- +104 ;;=C21.0^^61^775^116
- +105 ;;^UTILITY(U,$J,358.3,16546,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,16546,1,3,0)
- +108 ;;=3^Malig Neop Anus,Unspec
- +109 ;;^UTILITY(U,$J,358.3,16546,1,4,0)
- +110 ;;=4^C21.0
- +111 ;;^UTILITY(U,$J,358.3,16546,2)
- +112 ;;=^5000930
- +113 ;;^UTILITY(U,$J,358.3,16547,0)
- +114 ;;=C67.9^^61^775^119
- +115 ;;^UTILITY(U,$J,358.3,16547,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,16547,1,3,0)
- +118 ;;=3^Malig Neop Bladder,Unspec
- +119 ;;^UTILITY(U,$J,358.3,16547,1,4,0)
- +120 ;;=4^C67.9
- +121 ;;^UTILITY(U,$J,358.3,16547,2)
- +122 ;;=^5001263
- +123 ;;^UTILITY(U,$J,358.3,16548,0)
- +124 ;;=C71.9^^61^775^123